Search Results - "Vicente, Elena"
-
1
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy
Published in European journal of neurology (01-06-2024)“…Background and purpose Generalized myasthenia gravis (gMG) continues to present significant challenges for clinical management due to an unpredictable disease…”
Get full text
Journal Article -
2
Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis
Published in European journal of neurology (01-06-2021)“…Background and purpose Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma…”
Get full text
Journal Article -
3
Distal hereditary motor neuropathies: Mutation spectrum and genotype–phenotype correlation
Published in European journal of neurology (01-04-2021)“…Background and purpose Distal hereditary motor neuropathies (dHMNs) are a heterogeneous group of disorders characterized by degeneration of the motor component…”
Get full text
Journal Article -
4
Rituximab treatment in myasthenia gravis
Published in Frontiers in neurology (02-10-2023)“…Myasthenia gravis (MG) is a chronic autoimmune disease mediated by antibodies against post-synaptic proteins of the neuromuscular junction. Up to 10%–30% of…”
Get full text
Journal Article -
5
Diagnostic utility of cortactin antibodies in myasthenia gravis
Published in Annals of the New York Academy of Sciences (01-01-2018)“…Patients with myasthenia gravis (MG) without antibodies to the acetylcholine receptor (AChR) or muscle‐specific tyrosine kinase (MuSK) have been classified as…”
Get full text
Journal Article -
6
Comment to “Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis”
Published in Journal of neuroimmunology (15-09-2021)“…•Cell-based assay is not the best technique to detect autoantibodies to intracellular antigens.•Anti-cortactin positive sera detected by ELISA should be…”
Get full text
Journal Article -
7
Clinical and therapeutic features of myasthenia gravis in adults based on age at onset
Published in Neurology (17-03-2020)“…OBJECTIVETo describe the characteristics of patients with very-late-onset myasthenia gravis (MG). METHODSThis observational cross-sectional multicenter study…”
Get full text
Journal Article -
8
Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin
Published in JAMA neurology (01-09-2016)“…Double-seronegative myasthenia gravis (dSNMG) includes patients with myasthenia gravis (MG) without detectable antibodies to the nicotinic acetylcholine…”
Get more information
Journal Article -
9
Editorial: New perspectives in the treatment of myasthenia gravis
Published in Frontiers in neurology (2024)Get full text
Journal Article -
10
Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis
Published in Journal of immunological methods (01-11-2024)“…In mouse models of myasthenia gravis (MG), anti-acetylcholine receptor (AChR) antibodies can be quantified to monitor disease progression and treatment…”
Get full text
Journal Article -
11
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
Published in Neurology (23-10-2018)“…OBJECTIVETo investigate the clinical utility of 3 CSF biomarkers along the clinical spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia…”
Get full text
Journal Article -
12
Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy
Published in Scientific reports (31-10-2017)“…Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous disease in which diverse autoantibodies have been described but systematic…”
Get full text
Journal Article -
13
A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
Published in Journal of the peripheral nervous system (01-03-2021)“…We report the case of a patient with a clinical phenotype characterized by distal lower limb weakness and pes cavus. The electrophysiological study showed…”
Get full text
Journal Article -
14
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity
Published in Nature communications (07-06-2022)“…Invariant NKT (iNKT) cells comprise a heterogeneous group of non-circulating, tissue-resident T lymphocytes that recognize glycolipids, including…”
Get full text
Journal Article -
15
Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia
Published in Neuromuscular disorders : NMD (01-08-2022)“…•Rituximab is effective in patients with myasthenia gravis.•Patients with Anti-MusK antibodies respond better.•Severe infections may appear after rituximab…”
Get full text
Journal Article -
16
Cortical microstructure in the amyotrophic lateral sclerosis–frontotemporal dementia continuum
Published in Neurology (03-11-2020)“…OBJECTIVETo characterize the cortical macrostructure and microstructure of behavioral and cognitive changes along the amyotrophic lateral sclerosis…”
Get full text
Journal Article -
17
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients
Published in Journal of neurology, neurosurgery and psychiatry (01-01-2021)“…ObjectiveTo study baseline serum neurofilament light chain (sNfL) levels as a prognostic biomarker in Guillain-Barré syndrome (GBS).MethodsWe measured NfL in…”
Get full text
Journal Article -
18
Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis
Published in Journal of neurology (01-07-2024)“…Serological tests are important to detect autoantibodies (autoAbs) in patients with autoimmune neuropathies (AN) and myasthenia gravis (MG) as they are…”
Get full text
Journal Article -
19
Myasthenia Gravis Treatment Updates
Published in Current treatment options in neurology (01-08-2020)“…Purpose of review This review presents an update of current treatment strategies for patients with myasthenia gravis (MG) depending on their clinical and…”
Get full text
Journal Article -
20
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum
Published in Brain (London, England : 1878) (05-07-2024)“…Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease (MND) that shares a common clinical, genetic and pathologic spectrum with…”
Get full text
Journal Article